Velesta Pharmaceuticals Private Limited
About Velesta Pharmaceuticals Private Limited
Data last updated:
Velesta Pharmaceuticals Private Limited is a private limited company based in Kalyan, Maharashtra, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 31 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC304721. Its GSTIN is 27AAGCV2718R1ZN (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pawan Kumar Udayraj Pandey and Sudhir Kumar Rajmal Gupta.
Its last annual general meeting (AGM) was held on 30 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 101 Krushnai Plaza Haji Malang Road, Pisavali Nr Essar Petrol Pump Kalyan East, Maharashtra, India – 421306.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.15 Lakh, a decline of 41% compared to the previous year. For the same year it recorded a net loss of ₹9.1 Lakh (net margin -53%) and EBITDA of -₹8.95 Lakh (EBITDA margin -52.2%). Revenue has grown at a compounded annual rate (CAGR) of 46% over three years and 52% over five years.
Company details
Contact details
Velesta Pharmaceuticals Private Limited's registered office is in Kalyan, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 101 Krushnai Plaza Haji Malang Road, Pisavali Nr Essar Petrol Pump Kalyan East, Maharashtra, India – 421306
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Velesta Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Velesta Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Velesta Pharmaceuticals Private Limited, buy the company report.
Financials of Velesta Pharmaceuticals Private Limited
FY 2025 filings availableVelesta Pharmaceuticals Private Limited reported revenue of ₹17.15 Lakh (down 41% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 41% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 52%. EBITDA fell 475% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -52.2% | ||||
| Net Profit Margin | -53% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Velesta Pharmaceuticals Private Limited, buy the company report.
Board of directors of Velesta Pharmaceuticals Private Limited
Velesta Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pawan Kumar Udayraj Pandey | Director | 07 May 2019 | 7 Years 6 Months | Current |
| Sudhir Kumar Rajmal Gupta | Director | 31 Jan 2018 | 8 Years 9 Months | Current |
| Swapnil Shivsanker Pandey | Director | 31 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Velesta Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunsence Pharmaceuticals Private Limited | ₹17.15 Lakh (FY 2025) | 2.0% | Patna, Bihar, India | |||
| Velesta Pharmaceuticals Private Limitedthis company | ₹17.15 Lakh (FY 2024) | -₹9.1 Lakh | -53% | -41.0% | Kalyan, Maharashtra, India | |
| Medon Pharmaceuticals Private Limited | ₹17.15 Lakh (FY 2025) | -58.0% | Ranchi, Jharkhand, India | |||
| Imolife Pharmaceuticals Private Limited | ₹17.13 Lakh (FY 2022) | 47.0% | Bareilly, Uttar Pradesh, India | |||
| Eyeandeye Pharmaceuticals Private Limited | ₹17.09 Lakh (FY 2024) | 114.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Velesta Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Velesta Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Velesta Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Velesta Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCV2718R1ZN | Maharashtra | Active | 14 Jun 2018 |
To see the full GST registrations and return filing status of Velesta Pharmaceuticals Private Limited, buy the company report.
Recent activity
Velesta Pharmaceuticals Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Pawan Kumar Udayraj Pandey was appointed as Director on 07 May 2019.
Frequently asked questions
Velesta Pharmaceuticals is an active private limited company based in Kalyan, Maharashtra, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 31 January 2018 (8+ years old) and is registered under CIN U74999MH2018PTC304721.
Velesta Pharmaceuticals has 3 current directors:
- Pawan Kumar Udayraj Pandey - Director
- Sudhir Kumar Rajmal Gupta - Director
- Swapnil Shivsanker Pandey - Director
The latest financial statements of Velesta Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 October 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Velesta Pharmaceuticals is 27AAGCV2718R1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Velesta Pharmaceuticals is U74999MH2018PTC304721. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Velesta Pharmaceuticals was incorporated on 31 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Velesta Pharmaceuticals by revenue are Sunsence Pharmaceuticals Private Limited, Medon Pharmaceuticals Private Limited, Imolife Pharmaceuticals Private Limited, Eyeandeye Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Pawan Kumar Udayraj Pandey was appointed as Director on 07 May 2019. Vandana Varinderkumar Sharma ceased to be Director on 01 Oct 2018. Sudhir Kumar Rajmal Gupta was appointed as Director on 31 Jan 2018. Velesta Pharmaceuticals has 4 board changes on record in total.
The registered office of Velesta Pharmaceuticals is at Shop No. 101 Krushnai Plaza Haji Malang Road, Pisavali Nr Essar Petrol Pump Kalyan East, Maharashtra, India – 421306.
Velesta Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
Velesta Pharmaceuticals can be reached at its registered office: Shop No. 101 Krushnai Plaza Haji Malang Road, Pisavali Nr Essar Petrol Pump Kalyan East, Maharashtra, India – 421306.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
